These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 67932)

  • 1. Transcallosally evoked potentials and the EEG in the decerebrate dog: actions of tryptaminergic, dopaminergic and adrenergic agonists.
    Pickworth WB; Sharpe LG; Martin WR
    Electroencephalogr Clin Neurophysiol; 1977 Jun; 42(6):809-16. PubMed ID: 67932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Pharmacol Biochem Behav; 1986 Feb; 24(2):393-9. PubMed ID: 3006088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
    Martin WR; Eades CG
    Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of some drugs on an evoked response sensitive to tetrahydrocannabinols.
    Boyd ES; Boyd EH; Brown LE
    J Pharmacol Exp Ther; 1974 Jun; 189(3):748-58. PubMed ID: 4210510
    [No Abstract]   [Full Text] [Related]  

  • 5. [N,N-dimethyltryptamine: first comparative results. Preliminary communication].
    Arnold OH
    Arzneimittelforschung; 1975 Jun; 25(6):972-4. PubMed ID: 1057950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
    Bradley PB; Briggs I
    Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the flexor reflex to LSD, tryptamine, 5-hydroxytryptophan, methoxamine, and d-amphetamine in acute and chronic spinal rats.
    Nozaki M; Bell JA; Vaupel DB; Martin WR
    Psychopharmacology (Berl); 1977 Nov; 55(1):13-8. PubMed ID: 414256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
    Adams LM; Geyer MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
    Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
    Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral analysis of mouse EEG after the administration of N,N-dimethyltryptamine.
    Morley BJ; Bradley RJ
    Biol Psychiatry; 1977 Dec; 12(6):757-69. PubMed ID: 271513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA; Peroutka SJ
    Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of LSD-like hallucinogens using the chronic spinal dog.
    Martin WR; Vaupel DB; Nozaki M; Bright LD
    Drug Alcohol Depend; 1978 Mar; 3(2):113-23. PubMed ID: 272982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.